The 3‐item short version of the Bayer‐ADL scale as a screening tool for distinguishing mild cognitive impairment from dementia in primary care

Abstract

Background: The increasing global prevalence of dementia, where early intervention can significantly impact treatment outcomes and costs, necessitates effective early diagnostic tools, particularly in primary care settings.

The paper